Rapport Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Rapport Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Rapport Therapeutics Inc.
Rating: 2.27558325
Author: Trendlyne DVM scores

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

27.35 1.05 (3.99%)

35.30% Fall from 52W High

426.2K

XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.3 / 100

Technically Bullish

81.7 / 100

No estimates available

Rapport Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rapport Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

35.30% Fall from 52W High

SWOT Analysis

Rapport Therapeutics Inc Live Price Chart